Mimi San Pedro has been promoted to president of ContourMed, Little Rock, Arkansas, CEO John Miller and the company¹s Board of Directors announced recently. San Pedro joined the company, which produces lifelike external custom breast prostheses for post-mastectomy patients, in July 2001 as vice president of sales and marketing. Before joining ContourMed, San Pedro was an advertising industry executive for 18 years. In March 2000, she was diagnosed with breast cancer. After a life-changing year of treatment and recovery, San Pedro decided to change her career as well, and became part of the ContourMed management team. According to Miller, San Pedro has drawn from her extensive advertising background to become the driving force in creating national brand awareness for the ContourMed product. Since 2001, ContourMed has expanded its network of retailers offering the product to more than 100 in 33 states and has fitted more than 500 women in its lightweight custom prosthesis. Last week, Miller informed the ContourMed Board of Directors that he will resign as CEO at the end of March to accept a position with a major chemical corporation in Philadelphia, Pennsylvania. Miller says that the opportunity in Philadelphia will take him and his wife "back home" to be closer to their two grandchildren and three grown children. "When John Miller joined ContourMed in 2001, we did not have a finalized product, any sales revenue or cash flow," said L. Daniel Eaton, ContourMed founder and board member. "The combination of his leadership and broad business skills has transformed the company from the research and development phase into an industry leader." Under Miller¹s leadership, the company doubled its annual sales last year and is on track to double sales again in 2004. "When you are responsible for building a company from the ground up, you experience a tremendous amount of pride and accomplishment," said Miller. "As I make this transition, I can¹t think of anyone better to lead this company going forward than Mimi San Pedro. She has been by my side through every phase of our growth, and I am confident that her skills and personal commitment will take this company to the next level." About ContourMed ContourMed uses proprietary 3-D scanning technology, tracing its origins to the Arkansas Cancer Research Center at UAMS. ContourMed was the first company to emerge from Arkansas BioVentures, the technology development incubator at UAMS. ContourMed was recently named a finalist in the Arkansas Business of the Year Awards and won a Medical Design Excellence Award, a program that recognizes significant international advancements in medical devices.
Mimi San Pedro has been promoted to president of ContourMed, Little Rock, Arkansas, CEO John Miller and the company¹s Board of Directors announced recently. San Pedro joined the company, which produces lifelike external custom breast prostheses for post-mastectomy patients, in July 2001 as vice president of sales and marketing. Before joining ContourMed, San Pedro was an advertising industry executive for 18 years. In March 2000, she was diagnosed with breast cancer. After a life-changing year of treatment and recovery, San Pedro decided to change her career as well, and became part of the ContourMed management team. According to Miller, San Pedro has drawn from her extensive advertising background to become the driving force in creating national brand awareness for the ContourMed product. Since 2001, ContourMed has expanded its network of retailers offering the product to more than 100 in 33 states and has fitted more than 500 women in its lightweight custom prosthesis. Last week, Miller informed the ContourMed Board of Directors that he will resign as CEO at the end of March to accept a position with a major chemical corporation in Philadelphia, Pennsylvania. Miller says that the opportunity in Philadelphia will take him and his wife "back home" to be closer to their two grandchildren and three grown children. "When John Miller joined ContourMed in 2001, we did not have a finalized product, any sales revenue or cash flow," said L. Daniel Eaton, ContourMed founder and board member. "The combination of his leadership and broad business skills has transformed the company from the research and development phase into an industry leader." Under Miller¹s leadership, the company doubled its annual sales last year and is on track to double sales again in 2004. "When you are responsible for building a company from the ground up, you experience a tremendous amount of pride and accomplishment," said Miller. "As I make this transition, I can¹t think of anyone better to lead this company going forward than Mimi San Pedro. She has been by my side through every phase of our growth, and I am confident that her skills and personal commitment will take this company to the next level." About ContourMed ContourMed uses proprietary 3-D scanning technology, tracing its origins to the Arkansas Cancer Research Center at UAMS. ContourMed was the first company to emerge from Arkansas BioVentures, the technology development incubator at UAMS. ContourMed was recently named a finalist in the Arkansas Business of the Year Awards and won a Medical Design Excellence Award, a program that recognizes significant international advancements in medical devices.